Abstract
Graft vs host disease is a serious immunological complication of allogeneic haematopoietic cell transplantation, leading to a significant morbidity and mortality. It occurs when donor T lymphocyte react to foreign host cells. The physiopathology is a more complex process implicating host tissues damage caused by the conditioning regimen, cytokines, cellular effectors implicated in the immune response such as donor lymphocytes T, antigen presenting cells and mechanisms of apoptosis. This review focuses on the physiopathological basis, risk factors, clinical aspects; prevention and current management strategies to treat graft vs host disease. Recent developments in our understanding of this bone marrow transplantation complication have profoundly influenced the practice of allogeneic haematopoietic cell transplantation. There is a growing realisation of the importance of a graft vs leukaemia effect, strategy, which has encouraged the development of less conditioning regimens. Segregation between graft vs host effect and graft vs leukaemia effect is a key challenge, and could lead to new efficient and specific immunotherapy.
References
Feb 1, 1992·The Journal of Experimental Medicine·F P NestelW S Lapp
Mar 7, 1991·The New England Journal of Medicine·J L Ferrara, H J Deeg
Jun 1, 1991·Transplantation·D WeisdorfA Filipovich
Aug 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·M SykesD H Sachs
Feb 1, 1996·The New England Journal of Medicine·E GoulmyJ J van Rood
Sep 1, 1996·Stem Cells·J L FerraraW Krenger
Jun 1, 1997·British Journal of Haematology·P A RowlingsM M Horowitz
Jun 26, 1999·Bone Marrow Transplantation·K S BakerB R Blazar
Aug 24, 1999·Immunology and Cell Biology·N L Harris, F Ronchese
Dec 14, 1999·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·J L FerraraN J Chao
Jul 14, 2000·Journal of Hematotherapy & Stem Cell Research·J L Ferrara
Jan 3, 2001·Nature Medicine·X C LiT B Strom
Mar 29, 2001·Experimental Hematology·H GokerN J Chao
Apr 20, 2001·Critical Reviews in Oncology/hematology·N BasaraA A Fauser
Nov 24, 2001·Blood·V T Ho, R J Soiffer
Aug 7, 2002·The Journal of Experimental Medicine·José L CohenBenoît L Salomon
Oct 9, 2002·The Journal of Experimental Medicine·Yosef RefaeliAbul K Abbas
Jun 12, 2003·Transfusion clinique et biologique : journal de la Société française de transfusion sanguine·P TiberghienP Hervé
Sep 10, 2003·Experimental Hematology·J H Frederik FalkenburgRoel Willemze
Nov 20, 2003·JAMA : the Journal of the American Medical Association·Vikas Bhushan, Robert H Collins
Jan 17, 2004·Transplantation·Aurélie TrenadoJosé L Cohen
Jan 22, 2004·Hematological Oncology·Pavan Reddy
May 4, 2004·Nature Reviews. Cancer·Marie Bleakley, Stanley R Riddell
Jun 1, 2004·International Journal of Hematology·Paul J MartinMary E Flowers
Jun 29, 2004·La Revue de médecine interne·S VinzioB Goichot
Dec 13, 2005·Autoimmunity Reviews·Yasunori IchikiM Eric Gershwin